Modifications produced by selective inhibitors of cyclooxygenase and ultra low dose aspirin on platelet activity in portal hypertension

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 38

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Oct 14, 2007; 13(38): 5065-5070
Published online Oct 14, 2007. doi: 10.3748/wjg.v13.i38.5065

Full Size Figure Download Figure

$[Label] $[Caption_0] $[Caption_1]

Citation: Eizayaga FX, Aguejouf O, Desplat V, Belon P, Doutremepuich C. Modifications produced by selective inhibitors of cyclooxygenase and ultra low dose aspirin on platelet activity in portal hypertension. World J Gastroenterol 2007; 13(38): 5065-5070
URL: https://www.wjgnet.com/1007-9327/full/v13/i38/5065.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i38.5065

Eizayaga FX, Aguejouf O, Desplat V, Belon P, Doutremepuich C. Modifications produced by selective inhibitors of cyclooxygenase and ultra low dose aspirin on platelet activity in portal hypertension. World J Gastroenterol 2007; 13(38): 5065-5070 [PMID: 17876871 DOI: 10.3748/wjg.v13.i38.5065]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.